Alvotech: Potential Victim Of Pharma Tariff Threats (Rating Downgrade)

If you like what you have just read and want to receive at least 4 exclusive stock tips every week focused on Pharma, Biotech and Healthcare, then join me at my marketplace channel, Haggerston BioHealth . Invest alongside the model portfolio, or simply access the investment bank-grade financial models and research. I hope to see you there.I last covered Alvotech (NASDAQ: ALVO ) for Seeking Alpha in a note published last August , in which I gave its stock a “Buy” rating. Shares traded at $12 at the time and ...